mometasone furoate

(redirected from Asmanex)

mometasone furoate

(mō-mĕt′ə-sōn′)
n.
A synthetic corticosteroid used as a topical anti-inflammatory and antipruritic, as a nasal spray in the treatment of allergic rhinitis, and as an inhalant in the maintenance treatment of asthma.
The American Heritage® Medical Dictionary Copyright © 2007, 2004 by Houghton Mifflin Company. Published by Houghton Mifflin Company. All rights reserved.

mometasone furoate

Asmanex®, Nasonex®, Twisthaler® Therapeutics An inhaled steroid used for seasonal allergic rhinitis and asthma
McGraw-Hill Concise Dictionary of Modern Medicine. © 2002 by The McGraw-Hill Companies, Inc.
Mentioned in ?
References in periodicals archive ?
Commonly prescribed ICSs for asthma are beclomethasone dipropionate (QVAR[R]), triamcinolone acetonide (Azmacort[R]), budesonide (Pulmicort[R]), flunisolide (AeroBid[R]), mometasone furoate (Asmanex Twisthaler[R]), fluticasone (Flovent[R]), and ciclesonide (Alvesco[R]).
Inhaled corticosteroids, including fluticasone (Flovent Diskus, Flovent HFA), mometasone (Asmanex), beclomethasone (Qvar), budesonide (Pulmicort Flexhaler), ciclesonide (Alvesco) and others, are the most commonly prescribed long-term asthma remedy.
The changes will result in ScheringPlough assuming exclusive worldwide rights to develop and commercialize a fixed-dose combination of its inhaled corticosteroid ASMANEX (mometasone furoate inhalation powder), and Novartis' long-acting beta2-adrenergic receptor agonist, FORADIL (formoterol fumarate).
Mometasone furoate (Asmanex Twisthaler) is available as a DPI with 220 micrograms/actuation dosing.
Asmanex Twisthaler (mometasone furoate inhalation powder, Schering-Plough Corp.) The Food and Drug Administration approved Asmanex Twisthaler for once-daily maintenance treatment of asthma in children aged 4-11 years.
The Asmanex Twisthaler is not indicated for treatment of acute asthma episodes.
Also for asthma patients who need oral corticosteroids, where adding Asmanex "may reduce or eliminate the need for oral corticosteroids." Mometasone has been available in topical ointment (Elocon) and nasal spray (Nasonex) formulations.
The manufacturing problems hurt 2001 earnings and have held up approvals of new products, such as experimental asthma drug Asmanex (search).
Inhaled corticosteroids, including fluticasone (Flovent Diskus, Flovent HFA), mometasone (Asmanex), beclomethasone (Qvar), budesonide (Pulmicort Flexhaler),ciclesonide (Alvesco) and others, are the most commonly prescribed long-term asthma remedy.
The FDA approved Asmanex Twisthaler 220 mcg (mometasone furoate inhalation powder) for first-line maintenance treatment of asthma as preventive therapy in patients aged 12 years and older.
Asmanex Twisthaler (mometasone furoate, Schering-Plough Inc.)